Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Nausea And Vomiting Treatment will have significant change from previous year. According to our latest study, the global Nausea And Vomiting Treatment market size is USD million in 2022 from USD 5082.5 million in 2021, with a change of % between 2021 and 2022. The global Nausea And Vomiting Treatment market size will reach USD 8025.1 million in 2028, growing at a CAGR of 6.7% over the analysis period.
The United States Nausea And Vomiting Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nausea And Vomiting Treatment market, reaching US$ million by the year 2028. As for the Europe Nausea And Vomiting Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nausea And Vomiting Treatment players cover Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), and Kyowa Kirin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nausea And Vomiting Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
CINV
PONV
Motion Sickness
Pregnancy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nausea And Vomiting Treatment Market Size 2017-2028
2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Nausea And Vomiting Treatment Segment by Type
2.2.1 Serotonin Receptor Antagonist
2.2.2 Neurokinin NK1 Receptor Antagonist
2.2.3 Others
2.3 Nausea And Vomiting Treatment Market Size by Type
2.3.1 Nausea And Vomiting Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
2.4 Nausea And Vomiting Treatment Segment by Application
2.4.1 CINV
2.4.2 PONV
2.4.3 Motion Sickness
2.4.4 Pregnancy
2.4.5 Others
2.5 Nausea And Vomiting Treatment Market Size by Application
2.5.1 Nausea And Vomiting Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
3 Nausea And Vomiting Treatment Market Size by Player
3.1 Nausea And Vomiting Treatment Market Size Market Share by Players
3.1.1 Global Nausea And Vomiting Treatment Revenue by Players (2020-2022)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nausea And Vomiting Treatment by Regions
4.1 Nausea And Vomiting Treatment Market Size by Regions (2017-2022)
4.2 Americas Nausea And Vomiting Treatment Market Size Growth (2017-2022)
4.3 APAC Nausea And Vomiting Treatment Market Size Growth (2017-2022)
4.4 Europe Nausea And Vomiting Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2017-2022)
5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2017-2022)
5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2017-2022)
6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2017-2022)
6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nausea And Vomiting Treatment by Country (2017-2022)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2017-2022)
8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nausea And Vomiting Treatment Market Forecast
10.1 Global Nausea And Vomiting Treatment Forecast by Regions (2023-2028)
10.1.1 Global Nausea And Vomiting Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Nausea And Vomiting Treatment Forecast
10.1.3 APAC Nausea And Vomiting Treatment Forecast
10.1.4 Europe Nausea And Vomiting Treatment Forecast
10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast
10.2 Americas Nausea And Vomiting Treatment Forecast by Country (2023-2028)
10.2.1 United States Nausea And Vomiting Treatment Market Forecast
10.2.2 Canada Nausea And Vomiting Treatment Market Forecast
10.2.3 Mexico Nausea And Vomiting Treatment Market Forecast
10.2.4 Brazil Nausea And Vomiting Treatment Market Forecast
10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2023-2028)
10.3.1 China Nausea And Vomiting Treatment Market Forecast
10.3.2 Japan Nausea And Vomiting Treatment Market Forecast
10.3.3 Korea Nausea And Vomiting Treatment Market Forecast
10.3.4 Southeast Asia Nausea And Vomiting Treatment Market Forecast
10.3.5 India Nausea And Vomiting Treatment Market Forecast
10.3.6 Australia Nausea And Vomiting Treatment Market Forecast
10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2023-2028)
10.4.1 Germany Nausea And Vomiting Treatment Market Forecast
10.4.2 France Nausea And Vomiting Treatment Market Forecast
10.4.3 UK Nausea And Vomiting Treatment Market Forecast
10.4.4 Italy Nausea And Vomiting Treatment Market Forecast
10.4.5 Russia Nausea And Vomiting Treatment Market Forecast
10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Nausea And Vomiting Treatment Market Forecast
10.5.2 South Africa Nausea And Vomiting Treatment Market Forecast
10.5.3 Israel Nausea And Vomiting Treatment Market Forecast
10.5.4 Turkey Nausea And Vomiting Treatment Market Forecast
10.5.5 GCC Countries Nausea And Vomiting Treatment Market Forecast
10.6 Global Nausea And Vomiting Treatment Forecast by Type (2023-2028)
10.7 Global Nausea And Vomiting Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Information
11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck & Co. Inc. Main Business Overview
11.1.5 Merck & Co. Inc. Latest Developments
11.2 Helsinn Group
11.2.1 Helsinn Group Company Information
11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered
11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Helsinn Group Main Business Overview
11.2.5 Helsinn Group Latest Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Information
11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Kyowa Kirin Main Business Overview
11.4.5 Kyowa Kirin Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered
11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Information
11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Qilu Pharma Main Business Overview
11.6.5 Qilu Pharma Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.8 Taiji group
11.8.1 Taiji group Company Information
11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered
11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Taiji group Main Business Overview
11.8.5 Taiji group Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Nausea And Vomiting Treatment Product Offered
11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Information
11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Heron Therapeutics Main Business Overview
11.10.5 Heron Therapeutics Latest Developments
11. Atnahs Pharma UK Limited
11.11.1 Atnahs Pharma UK Limited Company Information
11.11.2 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered
11.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Atnahs Pharma UK Limited Main Business Overview
11.11.5 Atnahs Pharma UK Limited Latest Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Nausea And Vomiting Treatment Product Offered
11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Mylan Main Business Overview
11.12.5 Mylan Latest Developments
11.13 Duchesnay
11.13.1 Duchesnay Company Information
11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered
11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Duchesnay Main Business Overview
11.13.5 Duchesnay Latest Developments
11.14 Tesaro
11.14.1 Tesaro Company Information
11.14.2 Tesaro Nausea And Vomiting Treatment Product Offered
11.14.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Tesaro Main Business Overview
11.14.5 Tesaro Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Nausea And Vomiting Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Serotonin Receptor Antagonist
Table 3. Major Players of Neurokinin NK1 Receptor Antagonist
Table 4. Major Players of Others
Table 5. Nausea And Vomiting Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
Table 8. Nausea And Vomiting Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Nausea And Vomiting Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Nausea And Vomiting Treatment Revenue Market Share by Player (2020-2022)
Table 13. Nausea And Vomiting Treatment Key Players Head office and Products Offered
Table 14. Nausea And Vomiting Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nausea And Vomiting Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Nausea And Vomiting Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Nausea And Vomiting Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Nausea And Vomiting Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Nausea And Vomiting Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Nausea And Vomiting Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Nausea And Vomiting Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Nausea And Vomiting Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Nausea And Vomiting Treatment
Table 44. Key Market Challenges & Risks of Nausea And Vomiting Treatment
Table 45. Key Industry Trends of Nausea And Vomiting Treatment
Table 46. Global Nausea And Vomiting Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Nausea And Vomiting Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Nausea And Vomiting Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Merck & Co. Inc. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 53. Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
Table 54. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Merck & Co. Inc. Main Business
Table 56. Merck & Co. Inc. Latest Developments
Table 57. Helsinn Group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 58. Helsinn Group Nausea And Vomiting Treatment Product Offered
Table 59. Helsinn Group Main Business
Table 60. Helsinn Group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Helsinn Group Latest Developments
Table 62. Unimed Pharmaceuticals (AbbVie Inc.) Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 63. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
Table 64. Unimed Pharmaceuticals (AbbVie Inc.) Main Business
Table 65. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
Table 67. Kyowa Kirin Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 68. Kyowa Kirin Nausea And Vomiting Treatment Product Offered
Table 69. Kyowa Kirin Main Business
Table 70. Kyowa Kirin Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Kyowa Kirin Latest Developments
Table 72. Sanofi Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 73. Sanofi Nausea And Vomiting Treatment Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Sanofi Latest Developments
Table 77. Qilu Pharma Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 78. Qilu Pharma Nausea And Vomiting Treatment Product Offered
Table 79. Qilu Pharma Main Business
Table 80. Qilu Pharma Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Qilu Pharma Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 83. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
Table 84. Teva Pharmaceutical Industries Ltd. Main Business
Table 85. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 87. Taiji group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 88. Taiji group Nausea And Vomiting Treatment Product Offered
Table 89. Taiji group Main Business
Table 90. Taiji group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Taiji group Latest Developments
Table 92. Novartis Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 93. Novartis Nausea And Vomiting Treatment Product Offered
Table 94. Novartis Main Business
Table 95. Novartis Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Novartis Latest Developments
Table 97. Heron Therapeutics Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 98. Heron Therapeutics Nausea And Vomiting Treatment Product Offered
Table 99. Heron Therapeutics Main Business
Table 100. Heron Therapeutics Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Heron Therapeutics Latest Developments
Table 102. Atnahs Pharma UK Limited Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 103. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Offered
Table 104. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Atnahs Pharma UK Limited Main Business
Table 106. Atnahs Pharma UK Limited Latest Developments
Table 107. Mylan Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 108. Mylan Nausea And Vomiting Treatment Product Offered
Table 109. Mylan Main Business
Table 110. Mylan Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Mylan Latest Developments
Table 112. Duchesnay Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 113. Duchesnay Nausea And Vomiting Treatment Product Offered
Table 114. Duchesnay Main Business
Table 115. Duchesnay Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Duchesnay Latest Developments
Table 117. Tesaro Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 118. Tesaro Nausea And Vomiting Treatment Product Offered
Table 119. Tesaro Main Business
Table 120. Tesaro Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Tesaro Latest Developments
List of Figures
Figure 1. Nausea And Vomiting Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nausea And Vomiting Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Nausea And Vomiting Treatment Market Size Market Share by Type in 2021
Figure 7. Nausea And Vomiting Treatment in CINV
Figure 8. Global Nausea And Vomiting Treatment Market: CINV (2017-2022) & ($ Millions)
Figure 9. Nausea And Vomiting Treatment in PONV
Figure 10. Global Nausea And Vomiting Treatment Market: PONV (2017-2022) & ($ Millions)
Figure 11. Nausea And Vomiting Treatment in Motion Sickness
Figure 12. Global Nausea And Vomiting Treatment Market: Motion Sickness (2017-2022) & ($ Millions)
Figure 13. Nausea And Vomiting Treatment in Pregnancy
Figure 14. Global Nausea And Vomiting Treatment Market: Pregnancy (2017-2022) & ($ Millions)
Figure 15. Nausea And Vomiting Treatment in Others
Figure 16. Global Nausea And Vomiting Treatment Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Nausea And Vomiting Treatment Market Size Market Share by Application in 2021
Figure 18. Global Nausea And Vomiting Treatment Revenue Market Share by Player in 2021
Figure 19. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)
Figure 21. APAC Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Europe Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Nausea And Vomiting Treatment Market Size 2017-2022 ($ Millions)
Figure 24. Americas Nausea And Vomiting Treatment Value Market Share by Country in 2021
Figure 25. Americas Nausea And Vomiting Treatment Consumption Market Share by Type in 2021
Figure 26. Americas Nausea And Vomiting Treatment Market Size Market Share by Application in 2021
Figure 27. United States Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Nausea And Vomiting Treatment Market Size Market Share by Region in 2021
Figure 32. APAC Nausea And Vomiting Treatment Market Size Market Share by Application in 2021
Figure 33. China Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Nausea And Vomiting Treatment Market Size Market Share by Country in 2021
Figure 40. Europe Nausea And Vomiting Treatment Market Size Market Share by Type in 2021
Figure 41. Europe Nausea And Vomiting Treatment Market Size Market Share by Application in 2021
Figure 42. Germany Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application in 2021
Figure 50. Egypt Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Nausea And Vomiting Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 56. APAC Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Europe Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 59. United States Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Canada Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 63. China Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Japan Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Korea Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 67. India Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Australia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Germany Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 70. France Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 71. UK Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Italy Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Russia Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Spain Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 77. Israel Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Nausea And Vomiting Treatment Market Size 2023-2028 ($ Millions)
